SAFC

Momentum building for Hydrostor’s Willow Rock Energy Storage Center as company reaches key permitting and interconnection milestones

Retrieved on: 
Monday, March 4, 2024
News, KERN, CAISO, SCE, Electricity, SAFC, Renewable energy

KERN COUNTY, CALIFORNIA, March 04, 2024 (GLOBE NEWSWIRE) -- Hydrostor, a global long duration energy storage (LDES) developer and operator, has filed a Supplemental Application for Certification (SAFC) for their Willow Rock Energy Storage Center project in California, demonstrating that momentum is building for the project that will provide 500 MWs or eight hours of energy storage to California.

Key Points: 
  • KERN COUNTY, CALIFORNIA, March 04, 2024 (GLOBE NEWSWIRE) -- Hydrostor, a global long duration energy storage (LDES) developer and operator, has filed a Supplemental Application for Certification (SAFC) for their Willow Rock Energy Storage Center project in California, demonstrating that momentum is building for the project that will provide 500 MWs or eight hours of energy storage to California.
  • The Willow Rock Energy Storage Center project is located in Kern County, which is California’s largest energy provider jurisdiction.
  • The Willow Rock facility will be Hydrostor’s third grid-scale A-CAES energy storage project and is part of a growing pipeline of significant Hydrostor projects around the world.
  • The Willow Rock Energy Storage Center is a 500 megawatt (MW), 4,000 megawatt-hour Advanced Compressed Air Energy Storage (A-CAES) facility that is under advanced development in Kern County, California.

Honda Aircraft Company Reveals Name and Key Milestones of New Light Jet: HondaJet Echelon

Retrieved on: 
Monday, October 16, 2023
Aircraft, SAFC, Workload, SAF, Automation, Family, Travel, Safety, Carbon, Honda HA-420 HondaJet, Honda Aircraft Company, Design review (U.S. government), CDR, Display, Airline, Exhibition

LAS VEGAS, Oct. 16, 2023 /PRNewswire/ -- Honda Aircraft Company today revealed "HondaJet Echelon" as the official name of its new light jet at 2023 National Business Aviation Convention and Exhibition (NBAA-BACE). The name signifies the company's visionary path for the next-generation business jet, elevating efficiency to new heights while also delivering premium comfort and convenience. A mockup of the HondaJet Echelon will stand alongside the HondaJet Elite II at 2023 NBAA-BACE from Oct 17-19, marking the first time Honda Aircraft Company has presented both pillars of its product family side-by-side.

Key Points: 
  • Product Family on Display for First Time at 2023 NBAA-BACE: HondaJet Echelon and HondaJet Elite II
    LAS VEGAS, Oct. 16, 2023 /PRNewswire/ -- Honda Aircraft Company today revealed "HondaJet Echelon" as the official name of its new light jet at 2023 National Business Aviation Convention and Exhibition (NBAA-BACE).
  • A mockup of the HondaJet Echelon will stand alongside the HondaJet Elite II at 2023 NBAA-BACE from Oct 17-19, marking the first time Honda Aircraft Company has presented both pillars of its product family side-by-side.
  • "The HondaJet Echelon was born to create a new category that transcends the travel experience on conventional light jets," said Honda Aircraft Company President & CEO Hideto Yamasaki.
  • The HondaJet Echelon, previously introduced as the HondaJet 2600 Concept in 2021, sets a new paradigm by offering a mid-sized jet experience in the light jet category.

HondaJet Elite II Makes its Public Debut at EBACE2023

Retrieved on: 
Monday, May 22, 2023
Aircraft, EBACE, SAF, Aviation, Honda HA-420 HondaJet, Carbon, FAA, SAFC, European Union Aviation Safety Agency, Honda Aircraft Company, EASA, Environment, Frontier: Elite II, Airline, Exhibition

The HondaJet Elite II will be on display throughout EBACE public days, May 23-25.

Key Points: 
  • The HondaJet Elite II will be on display throughout EBACE public days, May 23-25.
  • "The HondaJet Elite II continues our dedication to exceeding the expectations of customers worldwide by setting new standards in performance, efficiency and comfort for the future of very light jets."
  • Honda Aircraft Company continues to demonstrate its long-standing commitment to the environment and sustainable aviation practices with the latest HondaJet Elite II.
  • The HondaJet Elite II has received type certification from the U.S. Federal Aviation Administration (FAA) and is expecting the European Union Aviation Safety Agency (EASA) type certification soon.

Curate Biosciences Announces David Backer as Chief Executive Officer

Retrieved on: 
Friday, December 16, 2022
NIH, Merck Millipore, Backer, SAFC, Red blood cell, Commercial, DCS, Patient, Sale, Cancer, Gene editing, Molecular medicine, Cell, Oxford BioMedica, Head, Trade, Sigma-Aldrich, Fine chemical, Curate

CARLSBAD, Calif., Dec. 16, 2022 /PRNewswire/ -- Curate Biosciences, a key enabling technology company for cell therapy manufacturing, today announced that David M. Backer will become the Company's next chief executive officer (CEO) and a member of Curate's Board of Directors. Backer brings decades of cell and gene therapy experience to the company as it looks to accelerate the production of life-saving medicines and change health outcomes for patients with intractable diseases. Founding CEO Michael Grisham will assume the responsibility of Chairman of the Board at Curate.

Key Points: 
  • CARLSBAD, Calif., Dec. 16, 2022 /PRNewswire/ -- Curate Biosciences, a key enabling technology company for cell therapy manufacturing, today announced that David M. Backer will become the Company's next chief executive officer (CEO) and a member of Curate's Board of Directors.
  • "I'm delighted to join Curate at this pivotal moment and help capitalize on the great work this team has done to develop a first-in-class technology," said Backer.
  • Backer most recently served as Chief Commercial Officer at Oxford Biomedica, and prior to that, was Senior Vice President, Commercial Development at cell and gene therapy-enabling tech company ElevateBio.
  • Curate Biosciences advances its platform technology The Curate Cell Processing System to allow a faster path to cleaner and larger quantities of starting cells, one of the significant bottlenecks in gene and cell therapies.